InvestSMART

ECS Botanics Holdings Ltd (ASX: ECS) - Announcements

Current share price for ECS : $0.005 0.001 (16.67%)+

ASX company news and announcements for ECS Botanics Holdings Ltd (ECS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ECS Botanics Holdings Ltd (ECS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ECS Botanics Holdings Ltd (ECS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ECS Botanics Holdings Ltd (ECS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8 Appendix 4G and Corporate Governance Statement 31 Aug 2021 3:22PM $0.035 $0.005 fallen by 85.71%
$8 Appendix 4E & Annual Report 31 Aug 2021 3:18PM $0.035 $0.005 fallen by 85.71%
$8 ECS secures $1.75m supply agreement into New Zealand 30 Aug 2021 8:52AM $0.034 $0.005 fallen by 85.29%
$8 AGM Date and Closing Date for Director Nominations 27 Aug 2021 3:59PM $0.034 $0.005 fallen by 85.29%
$8 Coles to stock ECS Hemp Seed Oil 16 Aug 2021 9:17AM $0.033 $0.005 fallen by 84.85%
$8 Change of Director's Interest Notice 9 Aug 2021 8:49AM $0.038 $0.005 fallen by 86.84%
$8 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2021 8:52AM $0.039 $0.005 fallen by 87.18%
$8 ECS secures $4.5m supply agreement into Europe 26 Jul 2021 8:51AM $0.041 $0.005 fallen by 87.80%
$8 Restricted Securities Released from Escrow 23 Jul 2021 8:22AM $0.040 $0.005 fallen by 87.50%
$8 Application for quotation of securities - ECS 23 Jul 2021 8:22AM $0.040 $0.005 fallen by 87.50%
$8 Change in substantial holding 9 Jul 2021 8:42AM $0.037 $0.005 fallen by 86.49%
$8 ECS appoints four industry leaders to support growth 2 Jul 2021 8:34AM $0.038 $0.005 fallen by 86.84%
$8 Secondary Trading Notice 30 Jun 2021 7:12PM $0.036 $0.005 fallen by 86.11%
$8 Application for quotation of securities - ECS 30 Jun 2021 7:12PM $0.036 $0.005 fallen by 86.11%
$8 Release from Escrow - 22 July 2021 18 Jun 2021 8:19AM $0.040 $0.005 fallen by 87.50%
$8 Strong sales growth following first commercial harvest 9 Jun 2021 8:48AM $0.041 $0.005 fallen by 87.80%
$8 ECS launches Innovative range of 30ml Terpene Blends 20 May 2021 9:56AM $0.036 $0.005 fallen by 86.11%
$8 Quarterly Activities Report and Appendix 4C 29 Apr 2021 8:44AM $0.046 $0.005 fallen by 89.13%
$8 Secondary Trading Notice & Appendix 2A 26 Apr 2021 9:29AM $0.047 $0.005 fallen by 89.36%
$8 Entitlement Issue Shortfall Notice 22 Apr 2021 8:21AM $0.049 $0.005 fallen by 89.80%
$8 Maiden commercial medicinal cannabis shipment dispatched 16 Apr 2021 2:57PM $0.052 $0.005 fallen by 90.38%
$8 Major Expansion planned for Tasmania 14 Apr 2021 8:22AM $0.050 $0.005 fallen by 90%
$8 Entitlement Offer - Letter to Eligible Shareholders 26 Mar 2021 9:33AM $0.051 $0.005 fallen by 90.20%
$8 Supply Agreement with Releaf Dispensaries 25 Mar 2021 8:22AM $0.050 $0.005 fallen by 90%
$8 Secondary Trading Notice & Appendix 2A 24 Mar 2021 12:24PM $0.050 $0.005 fallen by 90%

226 - 250 of 413 results

Page 10 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.